keyword
https://read.qxmd.com/read/38637754/an-economic-evaluation-of-eptinezumab-for-the-preventive-treatment-of-migraine-in-the-uk-with-consideration-for-natural-history-and-work-productivity
#21
JOURNAL ARTICLE
Edward Griffin, Gawain Shirley, Xin Ying Lee, Susanne F Awad, Alok Tyagi, Peter J Goadsby
BACKGROUND: Migraine is a highly prevalent neurological disease with a substantial societal burden due to lost productivity. From a societal perspective, we assessed the cost-effectiveness of eptinezumab for the preventive treatment of migraine. METHODS: An individual patient simulation of discrete competing events was developed to evaluate eptinezumab cost-effectiveness compared to best supportive care for adults in the United Kingdom with ≥ 4 migraine days per month and prior failure of ≥ 3 preventive migraine treatments...
April 18, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38637736/dynamic-fluctuations-of-salivary-cgrp-levels-during-migraine-attacks-association-with-clinical-variables-and-phenotypic-characterization
#22
JOURNAL ARTICLE
Alicia Alpuente, Victor J Gallardo, Laila Asskour, Edoardo Caronna, Marta Torres-Ferrus, Patricia Pozo-Rosich
BACKGROUND: Migraine is a complex neurological disorder with significant heterogeneity in its clinical presentation and molecular mechanisms. Calcitonin gene-related peptide (CGRP) has emerged as a key player in migraine pathophysiology, but challenges remain in its utilization as a biomarker. This study aimed to investigate salivary CGRP levels during migraine attacks across the frequency spectrum and explore associations with clinical variables. METHODS: A prospective longitudinal pilot study was conducted, recruiting migraine patients from an outpatient headache clinic...
April 18, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38635269/somatic-and-posttraumatic-stress-symptoms-in-children-and-adolescents-in-france
#23
JOURNAL ARTICLE
Arnaud Fernandez, Florence Askenazy, Radia Zeghari, Philippe Auby, Philippe Robert, Susanne Thümmler, Morgane Gindt
IMPORTANCE: Somatic symptoms are a major concern among the pediatric population because of frequency and burden. The association between adverse childhood experiences and somatic symptoms in adults is well established but less is known concerning somatic symptoms in young people. OBJECTIVE: To explore the frequency and intensity of somatic symptoms in children and adolescents exposed to traumatic events. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study was conducted from January 1 to December 31, 2021, at the Nice Pediatric Psychotrauma Referral Center in Nice, France...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38635020/focused-update-on-migraine-and-vertigo-comorbidity
#24
REVIEW
Tzu-Chou Huang, Qadeer Arshad, Amir Kheradmand
PURPOSE OF REVIEW: To provide an update on comorbidity of vestibular symptoms and migraine. RECENT FINDINGS: Multisensory processing and integration is a key concept for understanding mixed presentation of migraine and vestibular symptoms. Here, we discuss how vestibular migraine should be distinguished from a secondary migraine phenomenon in which migraine symptoms may coincide with or triggered by another vestibular disorder. We also have some updates on the diagnostic criteria of vestibular migraine, its pathophysiology, and common approaches used for its treatment...
April 18, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38634622/depression-and-anxiety-are-not-associated-with-migraine-outcomes-in-children-and-adolescents
#25
EDITORIAL
Amy A Gelfand
No abstract text is available yet for this article.
April 18, 2024: Headache
https://read.qxmd.com/read/38634515/nonspecific-oral-medications-versus-anti-calcitonin-gene-related-peptide-monoclonal-antibodies-for-migraine-a%C3%A2-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#26
REVIEW
Jennifer Robblee, Sameh M Hakim, John M Reynolds, Teshamae S Monteith, Niushen Zhang, Meredith Barad
OBJECTIVE: To compare calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) versus nonspecific oral migraine preventives (NOEPs). BACKGROUND: Insurers mandate step therapy with NOEPs before approving CGRP mAbs. METHODS: Databases were searched for class I or II randomized controlled trials (RCTs) comparing CGRP mAbs or NOEPs versus placebo for migraine prevention in adults. The primary outcome measure was monthly migraine days (MMD) or moderate to severe headache days...
April 18, 2024: Headache
https://read.qxmd.com/read/38633587/migraine-and-its-treatment-from-the-medicinal-chemistry-perspective
#27
REVIEW
Ezgi Pehlivanlar, Simone Carradori, Rahime Simsek
Migraine is a disease of neurovascular origin that affects the quality of life of more than one billion people and ranks sixth among the most common diseases in the world. Migraine is characterized by a moderate or severe recurrent and throbbing headache, accompanied by nausea, vomiting, and photo-phonophobia. It usually starts in adolescence and is twice as common in women as in men. It is classified as with or without aura and has chronic or acute treatment types according to the frequency of occurrence. In acute treatment, analgesics that relieve pain in the fastest way are preferred, while there are different options in chronic treatment...
April 12, 2024: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38630960/differences-in-cortical-morphology-in-people-with-and-without-migraine-a-registry-for-migraine-reform-mri-study
#28
JOURNAL ARTICLE
Rune H Christensen, Håkan Ashina, Haidar M Al-Khazali, Yixin Zhang, Daniel Tolnai, Amanda H Poulsen, Alessandro Cagol, Nouchine Hadjikhani, Cristina Granziera, Faisal Mohammad Amin, Messoud Ashina
BACKGROUND AND OBJECTIVES: Structural imaging can offer insights into the cortical morphometry of migraine, which might reflect adaptations to recurring nociceptive messaging. This study compares cortical morphometry between a large sample of people with migraine and healthy controls, as well as across migraine subtypes. METHODS: Adult participants with migraine and age-matched and sex-matched healthy controls attended a single MRI session with magnetization-prepared rapid acquisition gradient echo and fluid-attenuated inversion recovery sequences at 3T...
May 2024: Neurology
https://read.qxmd.com/read/38627638/rimegepant-orally-disintegrating-tablet-75%C3%A2-mg-for-acute-treatment-of-migraine-in-adults-from-china-a-subgroup-analysis-of-a-double-blind-randomized-placebo-controlled-phase-3-clinical-trial
#29
RANDOMIZED CONTROLLED TRIAL
Shengyuan Yu, Aihong Guo, Zhen Wang, Jianguang Liu, Ge Tan, Qian Yang, Mingjie Zhang, Hasiyeti Yibulaiyin, Huisheng Chen, Yongbo Zhang, Robert Croop, Yanhui Sun, Yu Liu, Qian Zhao, Zhihong Lu
BACKGROUND: Rimegepant orally disintegrating tablet (ODT), an oral small-molecule calcitonin gene-related peptide receptor antagonist, is indicated for acute and preventive treatment of migraine in the United States and other countries. Previously, a large clinical trial assessed the efficacy and safety of rimegepant ODT 75 mg for the acute treatment of migraine in adults living in China or South Korea. A post hoc subgroup analysis of this trial was performed to evaluate the efficacy and safety of rimegepant for acute treatment of migraine in adults living in China...
April 16, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38627631/effects-of-pde-3-inhibition-in-persistent-post-traumatic-headache-evidence-of-camp-dependent-signaling
#30
RANDOMIZED CONTROLLED TRIAL
Haidar M Al-Khazali, Rune H Christensen, Basit Ali Chaudhry, Anna G Melchior, Messoud Ashina, Rami Burstein, Håkan Ashina
BACKGROUND: Phosphodiesterase 3 (PDE-3) inhibition have been implicated in the neurobiologic underpinnings of migraine. Considering the clinical similarities between migraine and persistent post-traumatic headache (PPTH), we aimed to ascertain whether PDE-3 inhibition can elicit migraine-like headache in persons with PPTH. METHODS: We tested cilostazol, which inhibits PDE-3, in a randomized, double-blind, placebo-controlled, two-way crossover study involving persons with PPTH attributed to mild traumatic brain injury...
April 17, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38627623/calcitonin-gene-related-peptide-a-possible-biomarker-in-migraine-patients-with-patent-foramen-ovale
#31
JOURNAL ARTICLE
Chaojie Li, Yu Yu, Ningning Li, Ya-Na Yin, Lianjun Zhang, Kehang Xie, Donghui Huang
BACKGROUND: Serum CGRP has been found to increase during migraine attack. However, whether CGRP can identify MA with PFO subtypes in MA remains unknown. This study aimed to investigate the differential expression of calcitonin gene-related peptide (CGRP) between migraine (MA) patients with and without patent foramen ovale (PFO), and to evaluate the predictive value of CGRP for MA with PFO. METHODS: A total of 153 patients with MA, 51 patients with PFO and 102 patients without...
April 16, 2024: BMC Neurology
https://read.qxmd.com/read/38626410/surgical-interventions-for-intractable-migraine-a-systematic-review-and-meta-analysis
#32
JOURNAL ARTICLE
Tahani Alrahbeni, Ahmed Mahal, Anas Alkhouri, Hadil Faris Alotaibi, Vineet Rajagopal, Ashish Behera, Khalid Al-Mugheed, Mahalaqua Nazli Khatib, Shilpa Gaidhane, Quazi Syed Zahiruddin, Muhammed Shabil, Ganesh Bushi, Sarvesh Rustagi, Neelima Kukreti, Prakasini Satapathy, Ranjan K Mohapatra, Arkadiusz Dziedzic, Bijaya Kumar Padhi
BACKGROUND: Migraine affects approximately 14-15% of the global population, contributing to nearly 5% of the world's health burden. When drug treatments prove ineffective for intractable migraines, highly specific surgical interventions emerge as potential solutions. We aimed to analyze surgical approaches for these refractory or intractable migraines through a systematic review and meta-analysis. METHODS: We conducted a literature search across databases such as PubMed, Scopus, Web of Science, and Embase, focusing on studies related to migraines and surgical outcomes...
April 15, 2024: International Journal of Surgery
https://read.qxmd.com/read/38625512/acute-treatment-patterns-migraine-burden-and-healthcare-resource-use-in-people-with-migraine-results-from-the-overcome-eu-observational-study
#33
JOURNAL ARTICLE
Stefan Evers, Grazia Dell'Agnello, Diego Novick, H Saygin Gonderten, Tommaso Panni, Julio Pascual
INTRODUCTION: The ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) European Union (EU) is part of an overarching population-based study program that also includes the United States and Japan. Here, we report data on the migraine/severe headache burden and the use of acute medication and healthcare resources in Spain and Germany. METHODS: OVERCOME (EU) was an online, non-interventional, cross-sectional survey conducted in adults in Spain and Germany between October 2020 and February 2021...
April 16, 2024: Pain and Therapy
https://read.qxmd.com/read/38625389/changes-in-retinal-nerve-fiber-layer-thickness-may-be-the-cause-of-post-covid-19-headaches
#34
JOURNAL ARTICLE
Mehmet Selim Gel, Ayhan Kanat, Demet Seker, Hakan Koc, Iskender Samet Daltaban, Huseyin Findik, Omer Lutfi Gundogdu
OBJECTIVE: The prevalence of post-COVID headaches is not low. The eye can be affected by this infection, but it is not clear yet what the relationship is between persistent headaches and the thickness of the retinal nerve fiber layer (RNFL) after COVID-19 infection this study aims to investigate the relationship between these subjects. METHODS: In this retrospective study, in patients who have had a persistent headache, SD-OCT analysis of RNFL was obtained, and RNLF thickness values before and after COVID-19 infection were analyzed...
April 16, 2024: Neurological Research
https://read.qxmd.com/read/38621724/napex-acupoint-thread-embedding-combined-with-metoprolol-tartrate-tablet-for-prophylactic-treatment-of-migraine-without-aura-a-randomized-controlled-trial
#35
RANDOMIZED CONTROLLED TRIAL
Lamei Tao, Renzhong Kou, Lanqing Liu, Dan Wang, Gangqi Fan
OBJECTIVES: To observe the efficacy of napex acupoint thread-embedding combined with metoprolol tartrate tablet for prophylactic treatment of migraine without aura, and to compare its efficacy with simple napex acupoint thread-embedding and simple metoprolol tartrate tablet. METHODS: A total of 105 patients with migraine without aura were randomized into a combination group (35 cases, 5 cases dropped out), a thread-embedding group (35 cases, 4 cases dropped out) and a western medication group (35 cases, 2 cases dropped out)...
April 12, 2024: Zhongguo Zhen Jiu, Chinese Acupuncture & Moxibustion
https://read.qxmd.com/read/38619053/vestibular-migraine-an-update
#36
JOURNAL ARTICLE
Maria D Villar-Martinez, Peter J Goadsby
PURPOSE OF REVIEW: We performed a narrative review of the recent findings in epidemiology, clinical presentation, mechanisms and treatment of vestibular migraine. RECENT FINDINGS: Vestibular migraine is an underdiagnosed condition that has a high prevalence among general, headache and neuro-otology clinics. Vestibular migraine has a bimodal presentation probably associated with a hormonal component in women. These patients could have a complex clinical phenotype including concomitant autonomic, inflammatory or connective tissue conditions that have a higher prevalence of psychological symptoms, which may mistakenly lead to a diagnosis of a functional neurological disorder...
April 16, 2024: Current Opinion in Neurology
https://read.qxmd.com/read/38618429/recurrent-headache-with-diplopia-a-common-presentation-of-an-uncommon-entity
#37
Olusegun J Oluwole, Zeeshan Khan, Ane M Crespo Cuevas, Andrea Lorente Miranda, Vittorio Iantorno
Recurrent painful ophthalmoplegic neuropathy (RPON) is a rare headache syndrome, the diagnosis of which can be daunting to those who are not familiar with it. It presents characteristically with recurrent ocular motor weakness and ipsilateral head pain without an underlying etiology and often has unique imaging findings. Even after the successful diagnosis of this entity, there are no published management guidelines. Here, we present the case of a 31-year-old man whom we diagnosed with RPON following two episodes of unilateral headache with ophthalmoplegia over a three-month period and treated successfully with high-dose steroids on both occasions...
March 2024: Curēus
https://read.qxmd.com/read/38617722/topiramate-induced-ocular-complications-case-series
#38
Sarita Lobo, Geover Joslen Lobo
UNLABELLED: Several ocular adverse effects have been attributed to Topiramate, a sulfonamide derivative. It can cause problems in the eye such as choroidal effusion syndrome, acute angle closure glaucoma, myopic shift, visual field defects, and Myokymia. If not identified early, it can be vision-threatening. It is commonly used for migraine prophylaxis, partial onset, and generalized tonic-clonic seizures. It has also been prescribed for bipolar disorder and alcoholism. The risk of adverse reactions with this drug is 3%...
2024: Romanian Journal of Ophthalmology
https://read.qxmd.com/read/38617553/sensory-processing-difficulties-and-occupational-therapy-outcomes-for-functional-neurological-disorder-a-retrospective-cohort-study
#39
JOURNAL ARTICLE
Kathryn E McCombs, Julie MacLean, Sara A Finkelstein, Susan Goedeken, David L Perez, Jessica Ranford
BACKGROUND AND OBJECTIVES: Occupational therapy (OT) consensus recommendations and articles outlining a sensory-based OT intervention for functional neurological disorder (FND) have been published. However, limited research has been conducted to examine the efficacy of OT interventions for FND. We performed a retrospective cohort study aimed at independently replicating preliminarily characterized sensory processing difficulties in patients with FND and reporting on clinical outcomes of a sensory-based OT treatment in this population...
June 2024: Neurology. Clinical Practice
https://read.qxmd.com/read/38617394/efficacy-of-probiotics-in-prevention-of-migraine-attacks-in-children-a-randomized-clinical-trial-study
#40
JOURNAL ARTICLE
Hassan Bazmamoum, Bentolhoda Keshtkarsohi, Younes Mohammadi, Afshin Fayyazi
OBJECTIVES: Migraine is a chronic and joint disease in children. The results of previous studies on the effectiveness of probiotics in preventing migraine attacks in children have been controversial. This study aims to investigate the effect of probiotics on migraine prophylaxis in children. MATERIALS & METHODS: In this clinical trial study, 41 children aged 5 to 15 with migraine enrolled the study in two control and intervention groups. Children in the intervention group (18 children) received propranolol at a dose of 1 mg per kilogram of body weight daily in two divided doses along with a 250 mg Yomogi capsule daily for three months, and children in the control group (23 children), received propranolol along with placebo for three months...
2024: Iranian Journal of Child Neurology
keyword
keyword
16345
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.